Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Krigel

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
AAOHN Journal : Official Journal of the American Association of Occupational Health Nurses|April 1, 1987
Interleukins, interferons and tumor necrosis factor in cancer treatmentR L Krigel
Annals of Internal Medicine|July 15, 1989
Kaposi sarcoma and alpha-interferon therapyR L Krigel
Annals of the New York Academy of Sciences|January 1, 1984
The natural history and treatment of epidemic Kaposi's sarcomaR L Krigel
The Journal of Infectious Diseases|July 1, 1986
Reversible neurotoxicity due to oral acyclovir in a patient with chronic lymphocytic leukemiaR L Krigel
American Journal of Hematology|February 1, 1988
Metastatic extramedullary plasmacytoma: a case report and review of the literature of a rare pseudocarcinomaH Akiyama, R L Krigel
Seminars in Oncology|June 1, 1995
High-dose therapy with stem cell infusion in lymphomaS C Cohen, R L Krigel
Seminars in Oncology|June 1, 1994
Dose-intensive ifosfamide/carboplatin/etoposide plus granulocyte-macrophage colony-stimulating factor for non-small cell lung cancerC S Palackdharry, R L Krigel
Seminars in Oncology|June 1, 1990
Epidemic Kaposi's sarcomaR L Krigel, A E Friedman-Kien
Cancer Treatment Reports|June 1, 1983
Kaposi's sarcoma: a new staging classificationR L Krigel, L J Laubenstein, F M Muggia
Cancer Research|November 1, 1983
Ribonucleotide content of mononuclear cells from normal subjects and patients with chronic lymphocytic leukemia: increased nicotinamide adenine dinucleotide concentration in chronic lymphocytic leukemia lymphocytesL F Liebes, R L Krigel, M Conklyn, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
AAOHN Journal : Official Journal of the American Association of Occupational Health Nurses|April 1, 1987
Interleukins, interferons and tumor necrosis factor in cancer treatmentR L Krigel
Annals of Internal Medicine|July 15, 1989
Kaposi sarcoma and alpha-interferon therapyR L Krigel
Annals of the New York Academy of Sciences|January 1, 1984
The natural history and treatment of epidemic Kaposi's sarcomaR L Krigel
The Journal of Infectious Diseases|July 1, 1986
Reversible neurotoxicity due to oral acyclovir in a patient with chronic lymphocytic leukemiaR L Krigel
American Journal of Hematology|February 1, 1988
Metastatic extramedullary plasmacytoma: a case report and review of the literature of a rare pseudocarcinomaH Akiyama, R L Krigel
Seminars in Oncology|June 1, 1995
High-dose therapy with stem cell infusion in lymphomaS C Cohen, R L Krigel
Seminars in Oncology|June 1, 1994
Dose-intensive ifosfamide/carboplatin/etoposide plus granulocyte-macrophage colony-stimulating factor for non-small cell lung cancerC S Palackdharry, R L Krigel
Seminars in Oncology|June 1, 1990
Epidemic Kaposi's sarcomaR L Krigel, A E Friedman-Kien
Cancer Treatment Reports|June 1, 1983
Kaposi's sarcoma: a new staging classificationR L Krigel, L J Laubenstein, F M Muggia
Cancer Research|November 1, 1983
Ribonucleotide content of mononuclear cells from normal subjects and patients with chronic lymphocytic leukemia: increased nicotinamide adenine dinucleotide concentration in chronic lymphocytic leukemia lymphocytesL F Liebes, R L Krigel, M Conklyn, et al.
Pageof 3